Dashboard
Manage Tickers

ZURA Zura Bio Ltd

Nasdaq zurabio.com


$ 3.27 $ -0.22 (-6.41 %)    

Friday, 17-Oct-2025 19:40:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 3.21
$ 3.33
$ 3.00 x 201
$ 3.91 x 100
$ 3.18 - $ 3.51
$ 0.97 - $ 5.07
1,070,548
na
38.52M
$ 0.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-25-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-28-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-12-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 04-11-2022 12-31-2021 10-K
16 11-19-2021 09-30-2021 10-Q
17 08-27-2021 03-31-2021 10-Q
18 08-27-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

zura-bio-ceo-robert-lisicki-to-take-medical-leave-kim-davis-appointed-interim-ceo
Zura Bio CEO Robert Lisicki To Take Medica...
10/10/2025 12:24:51

-SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 17:06:34

chardan-capital-maintains-buy-on-zura-bio-maintains-10-price-target
Chardan Capital Maintains Buy on Zura Bio,...
09/30/2025 11:19:59

Chardan Capital analyst Daniil Gataulin maintains Zura Bio (NASDAQ:ZURA) with a Buy and maintains $10 price target.

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
09/29/2025 17:06:50

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
09/29/2025 12:09:33

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

why-merus-shares-are-trading-higher-by-38-here-are-20-stocks-moving-premarket
Why Merus Shares Are Trading Higher By 38%...
09/29/2025 09:07:53

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus fo...

hc-wainwright--co-maintains-neutral-on-zura-bio-lowers-price-target-to-2
HC Wainwright & Co. Maintains Neutral on Z...
08/19/2025 10:55:37

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Zura Bio (NASDAQ:ZURA) with a Neutral and lowers the price targ...

oppenheimer-maintains-outperform-on-zura-bio-lowers-price-target-to-16
Oppenheimer Maintains Outperform on Zura B...
08/15/2025 14:37:58

Oppenheimer analyst Justin Kim maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $17 to $16.

chardan-capital-maintains-buy-on-zura-bio-maintains-10-price-target
Chardan Capital Maintains Buy on Zura Bio,...
08/15/2025 12:09:09

Chardan Capital analyst Daniil Gataulin maintains Zura Bio (NASDAQ:ZURA) with a Buy and maintains $10 price target.

zura-bio-q2-eps-017-beats-018-estimate
Zura Bio Q2 EPS $(0.17) Beats $(0.18) Esti...
08/14/2025 12:21:34

Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.18) by 7...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
07/17/2025 17:06:01

zura-bio-appoints-eric-hyllengren-as-cfo-succeeding-verender-badial-effective-july-7-2025
Zura Bio Appoints Eric Hyllengren As CFO, ...
07/01/2025 10:31:42

zura-bio-launches-global-phase-2-tibushield-study-to-evaluate-tibulizumab-in-adults-with-hidradenitis-suppurativa-topline-results-for-primary-efficacy-endpoint-at-week-16-along-with-key-secondary-and-exploratory-outcomes-are-anticipated-in-third-quarter-of-2026
Zura Bio Launches Global Phase 2 TibuSHIEL...
05/20/2025 10:34:51

oppenheimer-maintains-outperform-on-zura-bio-lowers-price-target-to-17
Oppenheimer Maintains Outperform on Zura B...
05/09/2025 17:50:19

Oppenheimer analyst Jeff Jones maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $19 to $17.

zura-bio-q1-eps-019-misses-015-estimate
Zura Bio Q1 EPS $(0.19) Misses $(0.15) Est...
05/08/2025 10:40:19

hc-wainwright--co-maintains-neutral-on-zura-bio-lowers-price-target-to-3
HC Wainwright & Co. Maintains Neutral on Z...
04/03/2025 11:02:26

HC Wainwright & Co. analyst Mitchell Kapoor maintains Zura Bio (NASDAQ:ZURA) with a Neutral and lowers the price target ...

oppenheimer-maintains-outperform-on-zura-bio-lowers-price-target-to-19
Oppenheimer Maintains Outperform on Zura B...
03/26/2025 17:02:44

Oppenheimer analyst Jeff Jones maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $20 to $19.

guggenheim-reiterates-buy-on-zura-bio-maintains-15-price-target
Guggenheim Reiterates Buy on Zura Bio, Mai...
03/26/2025 13:44:37

Guggenheim analyst Yatin Suneja reiterates Zura Bio (NASDAQ:ZURA) with a Buy and maintains $15 price target.

chardan-capital-maintains-buy-on-zura-bio-lowers-price-target-to-10
Chardan Capital Maintains Buy on Zura Bio,...
03/26/2025 12:02:19

Chardan Capital analyst Matthew Barcus maintains Zura Bio (NASDAQ:ZURA) with a Buy and lowers the price target from $12 to $10.

zura-bio-posts-fy24-net-loss-of-060
Zura Bio Posts FY24 Net Loss Of $0.60
03/25/2025 10:47:05

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION